Stem Cell Research in Multiple Sclerosis

The blood–brain barrier is a highly specialised interface that regulates the movement of cells, molecules and nutrients between the circulation and the central nervous system. But what happens when this critical barrier becomes dysfunctional in multiple sclerosis? In this episode ...  Show more

Can growing amounts of real-world MS data help clinicians predict disease progression and make more personalised treatment decisions? In this episode of the ECTRIMS Podcast, host Brett Drummond speaks with Dr. Will Brown from Cambridge University and Dr. Carmen Tur from CEMCAT ab ...  Show more

<span data-sheets-value= "{"1":2,"2":"Read the related article in Neurology® "}" data-sheets-userformat= "{"2":13185,"3":{"1":0},"10":1,"11":4,"12":0,"15":"Calibri","16":12}"> Dr. Shuvro Roy talks with Dr. Matilde Inglese about comparing stem-cell transplants to DMTs in patien ...

This is MS Talks 2.0, Let’s Discuss Facts,a series brought to you by Novartis. Multiple sclerosis is an incurable disease.And if you receive a diagnosis, there can be a tendency to seek different approaches such as stem cell therapy, in search of an elusive cure.In this episode, ...  Show more

An interview with Dr Chloe Anthias, medical director of the new Cell Collection Centre has just opened by Anthony Nolan charity as part of our NIHR Nottingham Clinical Research Facility. Links a little while ago I talked to Prof Mark Bishton, who’s an oncologist at the hospital a ...  Show more

With over 20 options, what is the best multiple sclerosis treatment for me? Selecting an appropriate disease-modifying therapy (DMT) needs to consider your risk of worsening disability over time. Your age, sex and race can affect your prognosis and can influence the power of trea ...  Show more